Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qian-Ying Ouyang

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|October 4, 2020
Remdesivir and COVID-19Lei-Yun Wang, Jia-Jia Cui, Qian-Ying Ouyang, et al.
Molecular Cancer|April 12, 2022
Reprogramming the tumor microenvironment by genome editing for precision cancer therapyKe Liu, Jia-Jia Cui, Yan Zhan, et al.
Molecular Therapy. Nucleic Acids|May 4, 2022
Pharmacoepitranscriptomic landscape revealing m6A modification could be a drug-effect biomarker for cancer treatmentKe Liu, Qian-Ying Ouyang, Yan Zhan, et al.
The EPMA Journal|July 26, 2021
Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitudeLei-Yun Wang, Jia-Jia Cui, Qian-Ying OuYang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 21, 2025
CSDE1 enhances genotoxic drug resistance in cancer by modulating RPA2 through CSDE1-eIF3a regulatory complexJia-Jia Cui, Cheng-Xian Guo, Jun Li, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|October 4, 2020
Remdesivir and COVID-19Lei-Yun Wang, Jia-Jia Cui, Qian-Ying Ouyang, et al.
Molecular Cancer|April 12, 2022
Reprogramming the tumor microenvironment by genome editing for precision cancer therapyKe Liu, Jia-Jia Cui, Yan Zhan, et al.
Molecular Therapy. Nucleic Acids|May 4, 2022
Pharmacoepitranscriptomic landscape revealing m6A modification could be a drug-effect biomarker for cancer treatmentKe Liu, Qian-Ying Ouyang, Yan Zhan, et al.
The EPMA Journal|July 26, 2021
Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitudeLei-Yun Wang, Jia-Jia Cui, Qian-Ying OuYang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 21, 2025
CSDE1 enhances genotoxic drug resistance in cancer by modulating RPA2 through CSDE1-eIF3a regulatory complexJia-Jia Cui, Cheng-Xian Guo, Jun Li, et al.
Pageof 1